| Entry |
|
|---|
| Name |
Testosterone (JAN/USP);
Androderm (TN);
Androgel (TN);
Axiron (TN);
Striant (TN);
Testim (TN) |
|---|
| Product |
|
|---|
| Generic |
TESTOSTERONE (Actavis Pharma), TESTOSTERONE (Actavis Pharma), TESTOSTERONE (Actavis Pharma), TESTOSTERONE (Actavis Pharma), TESTOSTERONE (Actavis Pharma), TESTOSTERONE (Alembic Pharmaceuticals), TESTOSTERONE (Aleor Dermaceuticals Limited), TESTOSTERONE (Amneal Pharmaceuticals NY LLC), TESTOSTERONE (Cipla USA), TESTOSTERONE (Dr. Reddy's Laboratories), TESTOPEL (Endo Pharmaceuticals), TESTOSTERONE (Lupin Pharmaceuticals), TESTOSTERONE (Lupin Pharmaceuticals), TESTOSTERONE (Northstar RxLLC), TESTOSTERONE (Par Pharmaceutical), TESTOSTERONE (Par Pharmaceutical), TESTOSTERONE (Par Pharmaceutical), TESTOSTERONE (Perrigo New York), TESTOSTERONE (Perrigo New York), TESTOSTERONE (TWi Pharmaceuticals), TESTOSTERONE (Upsher-Smith Laboratories), TESTOSTERONE (Xiromed), TESTOSTERONE (Zydus Pharmaceuticals USA) |
|---|
| Formula |
C19H28O2
|
|---|
| Exact mass |
288.2089
|
|---|
| Mol weight |
288.4244
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG00460): | D00075<US> D00957<US> D00958<JP/US> D06087<US> |
|
|---|
| Efficacy |
Replenisher (androgen), Androgen receptor agonist |
|---|
| Disease |
Hypogonadotropic hypogonadism [DS: H00255] |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07226 | Progesterone, androgen and estrogen receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03B ANDROGENS
G03BA 3-oxoandrosten (4) derivatives
G03BA03 Testosterone
D00075 Testosterone (JAN/USP) <US>
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Androgens
Testosterone
D00075 Testosterone (JAN/USP)
Classification of Japanese OTC drugs [BR:br08313]
Agents for urogenital organs and anus
31 Other drugs for urogenital organs and anus
D00075 Testosterone (JAN/USP)
Agents for integumentary system
61 Other agents for integumentary system
D00075 Testosterone (JAN/USP)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Testosterone
D00075 Testosterone (JAN/USP)
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D00075 Testosterone (JAN/USP) <US>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 21
1 C1x C 28.5514 -18.0276
2 C5x C 28.5514 -19.4309
3 C2x C 29.7441 -20.1325
4 C2y C 31.0070 -19.4309
5 C1z C 31.0070 -18.0276
6 C1x C 29.7441 -17.3260
7 C1x C 32.1998 -20.1325
8 C1x C 33.3925 -19.4309
9 C1y C 33.3925 -18.0276
10 C1y C 32.1998 -17.3260
11 C1y C 34.6554 -17.3260
12 C1z C 34.6554 -15.9228
13 C1x C 33.3925 -15.2212
14 C1x C 32.1998 -15.9228
15 O5x O 27.3586 -20.1325
16 C1a C 34.6554 -14.5195
17 C1a C 31.0070 -16.6244
18 C1x C 37.0803 -17.3260
19 C1x C 37.0803 -15.9228
20 C1y C 35.8678 -15.2228
21 O1a O 35.8678 -13.8228
BOND 24
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 2 15 2
18 12 16 1 #Up
19 5 17 1 #Up
20 11 18 1
21 18 19 1
22 19 20 1
23 12 20 1
24 20 21 1 #Up
|
|---|
